Share
710 Posts.
lightbulb Created with Sketch. 274
clock Created with Sketch. 27/01/21
14:50
Share
Originally posted by tuts
↑
Primary endpoint for each specific patient is 15 days from first dose, however, it is likely (and I HOPE) we will not hear any news till completion of recruitment and after Data Review, which takes place at the end of completion, 15 days after the last patient is dosed.
Expand
it will be interesting to see of course how this compares to Mesoblast. MSB showed great early promise in its COVID-19 trial, to only be stopped early by the DSMB concluding that it wasn't going to meet its primary end points.
(20min delay)